KLK3 and prostate cancer: Currently, prostate cancer is diagnosed in early stages by elevated serum prostate-specific antigen (PSA) levels, by clinical symptoms, and by imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT) and transrectal ultrasound, and finally confirmed by prostate biopsy.